Medical Treatment of Endometriosis-Associated Pelvic Pain
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The Specific Aim of this project is to compare the efficacy and cost-effectiveness of
continuous oral contraceptives versus leuprolide/norethindrone in the treatment of
endometriosis-associated chronic pelvic pain. This comparison will be based on a randomized,
double-blind, trial of women with chronic pelvic pain who have been diagnosed with
endometriosis at the time of surgery within the last 3 years. We hypothesize that, over a
12-month period of postoperative treatment, the efficacy of oral contraceptives is no worse
than leuprolide/norethindrone, and that treatment with oral contraceptives is more
cost-effective.
Phase:
Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)